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Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder that has substantial 
impact on quality of life.  
Up to 50% of those affected use complementary and alternative medicine (CAM) (Kong et al., 2005) 
despite the fact any benefits of CAM have yet to be fully demonstrated by primary research data.
Conversely there is evidence to show psychological intervention is beneficial in terms of improved 
quality of life (Jarret et al., 2009).
In the absence of established aetiology illness perceptions have been implicated in the maintenance of 
symptoms and healthcare seeking (van Dulmen, Fennis & Bliejenberg, 1998).  
In general populations, illness and treatment (including CAM) perceptions have been shown to 
influence CAM use (Bishop, Lewith & Yardley, 2006).
Establishing distinct elements of illness and treatment perceptions which are influential in CAM use, 
using the common-sense model of illness representations (CSM, Leventhal, Brissette & Leventhal., 
2003), may indicate where psychological intervention could be directed to potentially help relieve 
troublesome symptoms. CSM based interventions have resulted in positive outcomes (e.g. Broadbent 
et al., 2009).  
653 participants with IBS completed an online survey, of which 546 (83.6%) were female.  
93.7% indicated they had been diagnosed with IBS.
Participants completed the Revised Illness Perception Questionnaire (IPQ-R) (Moss-Morris et 
al., 2002), the Beliefs about Medicines Questionnaire (BMQ-General) (Horne, Weinman & 
Hankins, 1999), the Complementary and Alternative Medicines Beliefs Inventory (CAMBI) 
(Bishop, Yardley & Lewith, 2005) and questions regarding CAM use. 
Unrelated t-tests compared illness and treatment perceptions of CAM-users compared to 
those not using CAM.  A binary logistic regression examined which factors predicted CAM use.
57% of participants reported using at least one form of CAM to relieve IBS symptoms.  The 
most popular CAM treatment was Herbal treatments (Figure 1).
CAM-users reported significantly stronger illness identity, illness consequences, medication 
harm beliefs and stronger emotional representations.  CAM-users also had more positive 
beliefs about CAM (Table 1).
Binary logistic regression analysis revealed 3-4 years (Odds ratio = 3.62) or over 5 years (3.19) 
since diagnosis (compared to past 12 months diagnosis), having A’ levels (1.89) or postgraduate 
qualifications (2.34) (compared to GCSEs) predicted CAM use (all p<.05).  
Stronger illness identity (1.10), consequences (1.07), cyclical timeline beliefs (1.08) and 
medication harm beliefs (1.10) predicted CAM use. Stronger perceptions of risk factors (e.g. 
smoking) resulted in a reduced likelihood of CAM use (Figure 2). 
Health psychology interventions which address components implicated in influencing CAM use may have potential to improve IBS symptom management and support patient’s informed decision 
making regarding treatment.
Intervention could be targeted at perceptions of consequences and emotional response in those affected by IBS.  It is possible CAM-users may gain the greatest benefit from such intervention. 
In consideration of some of the CAM used (Figure 1), CAM-users may be attempting to treat a perceived cause e.g. stress. Findings also offer some statistical support for supposition of the CSM in terms 
illness and treatment perceptions influencing a specific coping procedure in CAM use.
Future studies could investigate participant ‘subgroups’ (e.g. newly diagnosed with IBS), IBS subtypes, users of different CAM modalities and influences on CAM beliefs.
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AIMS
Using an ‘extended’ CSM framework (e.g. Bishop et al., 2006) the aims of the study were: 1) examine 
prevalence of CAM use in those affected by IBS; 2) to examine differences between CAM-users and 
non-users on measures of illness and treatment perceptions; 3) to examine which demographic, illness 
and treatment perceptions predicted CAM use. 
CAM Use
Illness Identity
OR = 1.10*
Timeline 
Cyclical
OR = 1.08*
Illness 
Consequences
OR = 1.07* Cause: Risk 
Factors
OR = .92*
BMQ Harm 
OR = 1.10*
Figure 1: Reported use of different CAM modalities in CAM-users with IBS (n=373)
Table 1: Descriptive statistics and t-tests for differences on CSM scale variables between 
CAM-users and non-users with IBS (significant effects in bold)
Figure 2: Odds Ratios (OR) for Illness and treatment perceptions that significantly 
predicted CAM use. 
*p<.05
*p<.05  **p<.01  ***p<.001 
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-.60
Yes 19.65 4.65
Treatment control No  14.22 3.81
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